Repare Therapeutics
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Building 2, 7171 Rue Frederick-Banting S...Phone Number
(857) 412-7018Website
www.reparerx.comRevenue
$11.9 MillionStock Symbol
RPTXIndustry
About Repare Therapeutics
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx ® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: RPTXShow moreRepare Therapeutics Org Chart
Compare Similar Companies to Repare Therapeutics
Compare insights from companies similar to Repare Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Repare Therapeutics
$11.9M
51-200
Public
$150.5M
2016
JO
Joseph O'ConnellExecutive VP, Clinical Development & Medical Affairs
Repare Therapeutics Tech Stack
A closer look at the technologies used by Repare Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Repare Therapeutics
Sign Up For FreeTo access detailed company insights
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx ® platform to systematically discover and develop highly targeted cancer therapies focused on genomic i... Read More